229 related articles for article (PubMed ID: 24550442)
21. Monitoring of Epstein-Barr virus load after hematopoietic stem cell transplantation for early intervention in post-transplant lymphoproliferative disease.
Meerbach A; Wutzler P; Häfer R; Zintl F; Gruhn B
J Med Virol; 2008 Mar; 80(3):441-54. PubMed ID: 18205222
[TBL] [Abstract][Full Text] [Related]
22. Hodgkin lymphoma, HIV, and Epstein-Barr virus in Malawi: Longitudinal results from the Kamuzu Central Hospital Lymphoma study.
Westmoreland KD; Stanley CC; Montgomery ND; Kaimila B; Kasonkanji E; El-Mallawany NK; Wasswa P; Mtete I; Butia M; Itimu S; Chasela M; Mtunda M; Chikasema M; Makwakwa V; Kampani C; Dhungel BM; Sanders MK; Krysiak R; Tomoka T; Liomba NG; Dittmer DP; Fedoriw Y; Gopal S
Pediatr Blood Cancer; 2017 May; 64(5):. PubMed ID: 27781380
[TBL] [Abstract][Full Text] [Related]
23. Host-Epstein-Barr virus relationship affected by immunostimulation in HIV-infected patients representing distinct progressor profile groups.
Friis AM; Åkerlund B; Gyllensten K; Aleman A; Ernberg I
Scand J Infect Dis; 2012 May; 44(5):388-92. PubMed ID: 22243136
[TBL] [Abstract][Full Text] [Related]
24. Epstein-Barr virus infects B and non-B lymphocytes in HIV-1-infected children and adolescents.
Bekker V; Scherpbier H; Beld M; Piriou E; van Breda A; Lange J; van Leth F; Jurriaans S; Alders S; Wertheim-van Dillen P; van Baarle D; Kuijpers T
J Infect Dis; 2006 Nov; 194(9):1323-30. PubMed ID: 17041860
[TBL] [Abstract][Full Text] [Related]
25. Differential dynamics of Epstein-Barr virus in individuals infected with human immunodeficiency virus-1 receiving intermittent interleukin-2 and antiretroviral therapy.
Burighel N; Ghezzi S; Nozza S; Del Bianco P; Lazzarin A; Tambussi G; Poli G; De Rossi A
Haematologica; 2006 Feb; 91(2):244-7. PubMed ID: 16461311
[TBL] [Abstract][Full Text] [Related]
26. Prevalence and risk factors for oral DNA tumor viruses in HIV-infected youth.
Kahn JA; Rudy BJ; Xu J; Kapogiannis B; Secord E; Gillison M
J Med Virol; 2016 Nov; 88(11):1944-52. PubMed ID: 27096166
[TBL] [Abstract][Full Text] [Related]
27. Early impairment of CD8+ T cells immune response against Epstein-Barr virus (EBV) antigens associated with high level of circulating mononuclear EBV DNA load in HIV infection.
Legoff J; Amiel C; Calisonni O; Fromentin D; Rajoely B; Abuaf N; Tartour E; Rozenbaum W; Bélec L; Nicolas JC
J Clin Immunol; 2004 Mar; 24(2):125-34. PubMed ID: 15024179
[TBL] [Abstract][Full Text] [Related]
28. Dynamics of Epstein-Barr virus in HIV-1-infected subjects on highly active antiretroviral therapy.
Righetti E; Ballon G; Ometto L; Cattelan AM; Menin C; Zanchetta M; Chieco-Bianchi L; De Rossi A
AIDS; 2002 Jan; 16(1):63-73. PubMed ID: 11741164
[TBL] [Abstract][Full Text] [Related]
29. Clinical and virologic manifestations of primary Epstein-Barr virus (EBV) infection in Kenyan infants born to HIV-infected women.
Slyker JA; Casper C; Tapia K; Richardson B; Bunts L; Huang ML; Maleche-Obimbo E; Nduati R; John-Stewart G
J Infect Dis; 2013 Jun; 207(12):1798-806. PubMed ID: 23493724
[TBL] [Abstract][Full Text] [Related]
30. [Epstein Barr viral load monitoring in mononuclear lymphocytes and serum of renal transplant recipients using a quantitative PCR protocol].
Merlino C; Giacchino F; Bergallo M; Bonello F; Bollero C; Segoloni GP; Cavallo R
G Ital Nefrol; 2003; 20(2):170-5. PubMed ID: 12746803
[TBL] [Abstract][Full Text] [Related]
31. Absolute level of Epstein-Barr virus DNA in human immunodeficiency virus type 1 infection is not predictive of AIDS-related non-Hodgkin lymphoma.
Van Baarle D; Wolthers KC; Hovenkamp E; Niesters HG; Osterhaus AD; Miedema F; Van Oers MH
J Infect Dis; 2002 Aug; 186(3):405-9. PubMed ID: 12134237
[TBL] [Abstract][Full Text] [Related]
32. Ganciclovir is associated with low or undetectable Epstein-Barr virus DNA load in cerebrospinal fluid of patients with HIV-related primary central nervous system lymphoma.
Bossolasco S; Falk KI; Ponzoni M; Ceserani N; Crippa F; Lazzarin A; Linde A; Cinque P
Clin Infect Dis; 2006 Feb; 42(4):e21-5. PubMed ID: 16421782
[TBL] [Abstract][Full Text] [Related]
33. Aberrant Epstein-Barr virus persistence in HIV carriers is characterized by anti-Epstein-Barr virus IgA and high cellular viral loads with restricted transcription.
Stevens SJ; Smits PH; Verkuijlen SA; Rockx DA; van Gorp EC; Mulder JW; Middeldorp JM
AIDS; 2007 Oct; 21(16):2141-9. PubMed ID: 18090040
[TBL] [Abstract][Full Text] [Related]
34. Blood Epstein-Barr virus DNA load and risk of progression to AIDS-related systemic B lymphoma.
Leruez-Ville M; Seng R; Morand P; Boufassa F; Boue F; Deveau C; Rouzioux C; Goujard C; Seigneurin JM; Meyer L
HIV Med; 2012 Sep; 13(8):479-87. PubMed ID: 22414000
[TBL] [Abstract][Full Text] [Related]
35. Relationship of immunosuppression to Epstein-Barr viral load and lymphoproliferative disease in pediatric heart transplant patients.
Schubert S; Renner C; Hammer M; Abdul-Khaliq H; Lehmkuhl HB; Berger F; Hetzer R; Reinke P
J Heart Lung Transplant; 2008 Jan; 27(1):100-5. PubMed ID: 18187094
[TBL] [Abstract][Full Text] [Related]
36. Relationship between non-Hodgkin's lymphoma and blood levels of Epstein-Barr virus in children in north-western Tanzania: a case control study.
Kabyemera R; Masalu N; Rambau P; Kamugisha E; Kidenya B; De Rossi A; Petrara MR; Mwizamuholya D
BMC Pediatr; 2013 Jan; 13():4. PubMed ID: 23294539
[TBL] [Abstract][Full Text] [Related]
37. High levels of Epstein-Barr virus DNA in saliva and peripheral blood from Ugandan mother-child pairs.
Mbulaiteye SM; Walters M; Engels EA; Bakaki PM; Ndugwa CM; Owor AM; Goedert JJ; Whitby D; Biggar RJ
J Infect Dis; 2006 Feb; 193(3):422-6. PubMed ID: 16388490
[TBL] [Abstract][Full Text] [Related]
38. Asymptomatic CMV Replication During Early Human Immunodeficiency Virus (HIV) Infection Is Associated With Lower CD4/CD8 Ratio During HIV Treatment.
Smith DM; Nakazawa M; Freeman ML; Anderson CM; Oliveira MF; Little SJ; Gianella S
Clin Infect Dis; 2016 Dec; 63(11):1517-1524. PubMed ID: 27601222
[TBL] [Abstract][Full Text] [Related]
39. Epstein-Barr virus viral load in human immunodeficiency virus-positive patients with reactive hemophagocytic syndrome.
Boisseau M; Lambotte O; Galicier L; Lerolle N; Marzac C; Aumont C; Coppo P; Fardet L
Infect Dis (Lond); 2015 Jun; 47(6):423-7. PubMed ID: 25746607
[TBL] [Abstract][Full Text] [Related]
40. Toward standardization of Epstein-Barr virus DNA load monitoring: unfractionated whole blood as preferred clinical specimen.
Stevens SJ; Pronk I; Middeldorp JM
J Clin Microbiol; 2001 Apr; 39(4):1211-6. PubMed ID: 11283029
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]